Abstract:Background/Aims: Percutaneous coronary intervention reduces acute myocardial infarction (MI)-induced mortality to a great extent, but effective treatments for MI-induced cardiac fibrosis and heart failure are still lacking. MicroRNAs (miRNAs) play a variety of roles in cells and have thus been investigated extensively. MicroRNA-223 (miR-223) expression has been reported to be altered in post-MI heart failure in humans; however, the roles of miR-223 in MI remain unknown. Our study aimed to elucidate the roles of miR-223 in cardiac fibrosis. Methods: Cultured cardiac fibroblasts (CFs) were activated by TGF-β1 stimulation. Gain and loss of miR-223 and RAS p21 protein activator 1 (RASA1) knockdown in CFs were achieved by transfecting the cells with miR-223 mimics and inhibitors, as well as small interfering RNA-RASA1 (siRASA1), respectively. Quantitative real-time reverse transcriptase-polymerase chain reactions (qRT-PCR) was used to determine miR-223-3p and RASA1 expression levels, and Cell Counting Kit-8 (CCK-8), transwell migration and scratch assays were performed to assess CFs viability and migration, respectively. Western blotting was used to detect collagen I, collagen III, alpha-smooth muscle actin (a-SMA), RASA1, p-Akt/t-Akt, p-MEK1/2/t-MEK1/2, and p-ERK1/2/t-ERK1/2 protein expressions, and immunofluorescence assays were used to detect the expression of α-actin, vimentin and α-SMA. Luciferase assays were carried out to determine whether miR-223 binds to RASA1. Rat models of MI were established by the ligation of the left anterior descending (LAD) coronary artery. MiR-223 inhibition in vivo was achieved via intramyocardial injections of the miR-223 sponge carried by adeno-associated virus 9 (AAV9). The cardiac function was detected by echocardiography, and cardiac fibrosis was shown by Masson’s trichrome staining. Results: miR-223 was increased in CFs compared to cardiomypcytes, and TGF-β1 treatment increased miR-223 expression in CFs. The miR-223 mimics enhanced cell proliferation and migration and collagen I, collagen III, and α-SMA protein expression in CFs, while the miR-223 inhibitors had contrasting effects and partially prevented the promoting effects of TGF-β1. qRT-PCR and western blotting revealed that miR-223 negatively regulated RASA1 expression, and the luciferase assays showed that miR-223 suppressed the luciferase activity of the RASA1 3’ untranslated region (3'UTR), indicating that miR-223 binds directly to RASA1. Similar to transfection with the miR-223 mimics, RASA1 knockdown enhanced cell proliferation and migration and collagen I, collagen III, and α-SMA protein expression in CFs. Moreover, RASA1 knockdown partially reversed the inhibitory effects of the miR-223 inhibitor on cell proliferation and migration and collagen I, collagen III, and α-SMA protein expression, indicating that the effects of miR-223 in CFs are partially mediated by the regulation of RASA1 expression. Further exploration showed that miR-223 mimics and siRASA1 promoted MEK1/2, ERK1/2 and AKT phosphorylation, while the miR-223 inhibitors had contrasting effects. The in vivo experiments confirmed the results of the in vitro experiments and showed that miR-223 inhibition prevented cardiac functional deterioration and cardiac fibrosis. Conclusions: miR-223 enhanced cell proliferation, migration, and differentiation in CFs, thus mediated cardiac fibrosis after MI partially via the involvement of RASA1.

SaO052MIR-30 FAMILY PREVENTS UPAR-INTEGRIN Β3 SIGNALING ACTIVATION TO PROTECT PODOCYTES

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

Downregulating ANGPTL3 by Mir-144-3p Promoted TGF-81-induced Renal Interstitial Fibrosis Via Activating PI3K/AKT Signaling Pathway

TGF2 and TGF3 isoforms drive fibrotic disease pathogenesis

TGFBR3 supports anoikis through suppressing ATF4 signaling

Therapeutic Targeting of Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis

A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.

Matrix Metalloproteinase 3 Regulates Angiotensin II‑induced Myocardial Fibrosis Cell Viability, Migration and Apoptosis.

Mtorc1 is a Key Regulator That Mediates OGD‑ and TGFβ1‑induced Myofibroblast Transformation and Chondroitin‑4‑sulfate Expression in Cardiac Fibroblasts

Gsta3 Attenuates Renal Interstitial Fibrosis by Inhibiting Tgf-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression

Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis Via MDM2

SIRT3 Inhibits Ang II-induced Transdifferentiation of Cardiac Fibroblasts Through Β-Catenin/ppar-γ Signaling

Antisense Oligonucleotides Against RhoA-ROKα Signaling Pathway Attenuates Α-Sm-actin Expression Induced by TGF-β1 in Adventitial Fibroblasts

Overexpression of Mir-133A-3p Inhibits Fibrosis and Proliferation of Keloid Fibroblasts by Regulating IRF5 to Inhibit the TGF-β/Smad2 Pathway

MicroRNA-223 Regulates Cardiac Fibrosis after Myocardial Infarction by Targeting RASA1

Activin A Activation Drives Renal Fibrosis Through the STAT3 Signaling Pathway.

Novel RAS Inhibitor 25-O-methylalisol F Attenuates Epithelial-to-mesenchymal Transition and Tubulo-Interstitial Fibrosis by Selectively Inhibiting TGF-β-mediated Smad3 Phosphorylation.

Effect of Phosphoinositide 3-Kinase on TNF-α Induced Proliferation, Apoptosis and the Expression of TGF-β1 in Airway Smooth Muscle Cells

Knockdown of Mir-214 Alleviates Renal Interstitial Fibrosis by Targeting the Regulation of the PTEN/PI3K/AKT Signalling Pathway